← Back to Search

Vit.D3 5000 IU, Immune Active for Immune Response (LIFEHOUSE Trial)

N/A
Waitlist Available
Led By Josesph J Lamb, MD
Research Sponsored by Metagenics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks (phase 1) or up to 6 months (phase 2)
Awards & highlights

LIFEHOUSE Trial Summary

This trial will offer employees complimentary supplementation with commercially available nutritional supplements to help improve their immune health. The results will be measured by blood parameters and questionnaire responses.

LIFEHOUSE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks (phase 1) or up to 6 months (phase 2)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks (phase 1) or up to 6 months (phase 2) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The benefit of nutritional supplements (Vit.D3 5000, Immune Active) on the improvement of health.
Secondary outcome measures
The benefit of nutritional supplements (Vit.D3 5000, Immune Active) on the improvement of quality of life.
The benefit of nutritional supplements (Vit.D3 5000, Immune Active) on the improvement of the absence of infections.
The benefit of nutritional supplements (Vit.D3 5000, Immune Active) on the improvement of weight and body composition.

LIFEHOUSE Trial Design

1Treatment groups
Experimental Treatment
Group I: Immune responseExperimental Treatment1 Intervention
This is a single-arm study. All subjects will be treated equally and will receive the same type and amount of nutritional supplements.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Vit.D3 5000 IU, Immune Active
2021
N/A
~10

Find a Location

Who is running the clinical trial?

Metagenics, Inc.Lead Sponsor
14 Previous Clinical Trials
1,409 Total Patients Enrolled
MetaProteomics LLCIndustry Sponsor
6 Previous Clinical Trials
1,044 Total Patients Enrolled
Josesph J Lamb, MDPrincipal InvestigatorMedical Director
~2 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top